In the current paper, we investigated whether immunizing mice using TLR4 ligand as adjuvant and 2 different antigens (HPV16 E7 peptide, soluble antigen OVA), and simultaneously blocking IL-10 signalling would lead to inflammation in the gut and cause autoimmune disease. This evidence concerns the gene IL10 and autoimmune disease.